JDRF Blog

Featured Post
How to self-advocate with your healthcare providers
Living with type 1 diabetes (T1D) is 24/7. Every day you must make decisions around meals, exercise, rest and more. It is the only condition that requires a daily manual […]
Read More

Canadian Institutes of Health Research (CIHR) and JDRF join forces to accelerate breakthroughs in stem cell-based research

Stem cell-based research has the potential to play a key role in developing a cure for type 1 diabetes (T1D). JDRF Canada is delighted to partner with the Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism and Diabetes to announce a new funding opportunity that will see $6M awarded to investigators driving stem cell-based therapies for T1D. This funding opportunity is part of JDRF and CIHR’s ongoing Partnership to Defeat Diabetes first announced in 2017.

ViaCyte Inc. Edmonton site currently recruiting

ViaCyte Inc., a privately held regenerative medicine company, is seeking residents of Alberta to participate in a promising JDRF-funded clinical trial in Edmonton. The purpose of this research is to determine the safety, tolerability and efficacy of PEC-Direct™ (also known as VC-02), an investigational therapy that may provide blood glucose control in a similar manner to what a “replacement pancreas” would do by producing insulin after it is surgically placed.

Working together to cure type 1

The first few months after Mirella Gallo’s 11-year-old daughter, Isabella, received a type 1 diabetes (T1D) diagnosis were very hard for her. “We were in shock and had no idea what it meant for her or our family”. With the support of Isabella’s nurses and doctors, the family learned how T1D would impact her day-to-day routine and her future. “We came to the realization that my daughter’s life would never be the same and that until a cure was found, she would be insulin dependent,” says Mirella.

Meet the winners of the Boston Pizza Foundation Future Prospects Award Program for JDRF!

We’re very excited to announce the winners of the Boston Pizza Foundation Future Prospects Award Program for JDRF! Through the generous support of Boston Pizza Foundation Future Prospects, the Program is awarding $5,000 dollars each for a total of $105,000 to help students living with type 1 diabetes (T1D) with tuition and book costs as they pursue post-secondary education in a university, college or trade school.

Making advocacy personal

Type 1 diabetes advocate, Samir Dattani, wants to make one thing clear; advocacy isn’t just about talking to members of Parliament. It can come in any form, so long as personal stories are being shared.

How one tech professional is spending his 50th dia-versary riding 200 miles to raise funds for T1D research

This year marks Miguel Alvarez’s 50th year living with type 1 diabetes (T1D). To recognize his monumental dia-versary, his sights are set on conquering two century-ride (100 mile) cycling challenges hosted by JDRF. The Sun Life Ride to Defeat Diabetes for JDRF iRides are destination rides in cities across the U.S. to raise funds for T1D research. Miguel’s journey is a remarkable testimony of how individuals living with T1D take control of their disease to pursue their passion.

The necessary evolution of how we fund a cure

“Our Ride first started with 8 stationary bikes and 20 people.”

Peter Oliver, one of the founders of the Oliver and Bonacini Restaurant Family and a passionate leader in the type 1 diabetes community, was there at the beginning.

Ask a Diabetes Nurse: Hannah Breadon

Throughout my career as a Diabetes Nurse Educator I have been asked all kinds of questions from people living with type 1 diabetes and their families. I’ve taken this opportunity to answer the most common questions about type 1 diabetes management. Here are just a few of the ones I hear most frequently.

Stay connected on the latest

  •  

Help Us Create a World Without Type 1 Diabetes

Give Now